Ekso Bionics Announces First Quarter 2024 Financial Results
- SAN RAFAEL, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2024.
- 04/29/2024
|
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024
- SAN RAFAEL, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2024 after the close of trading on Monday, April 29, 2024. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
- 04/22/2024
|
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal
- SAN RAFAEL, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Pricing, Data Analysis, and Coding (“PDAC”) contractor for the Centers for Medicare & Medicaid Services (“CMS”) has determined a final payment level of $91,031.93 for Medicare reimbursement of the Ekso Indego Personal, which took effect on April 1, 2024.
- 04/12/2024
|
Ekso Bionics Holdings, Inc. (EKSO) Q4 2023 Earnings Call Transcript
- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome Wong - Chief Financial Officer Jason Jones - Chief Operating Officer Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Ben Haynor - Alliance Global Partners Operator Greetings, and welcome to the Ekso Bionics' Fourth Quarter 2023 Financial Results Conference Call.
- 03/04/2024
|
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
- Ekso Bionics (EKSO) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.24 per share a year ago.
- 03/04/2024
|
Ekso Bionics Reports Record Annual Revenue of $18.3 Million
- Sold Record Number of Annual EksoHealth Units in 2023 SAN RAFAEL, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months ended December 31, 2023.
- 03/04/2024
|
Here's Why Ekso Bionics (EKSO) Is a Great 'Buy the Bottom' Stock Now
- Ekso Bionics (EKSO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
- 02/06/2024
|
Best Momentum Stocks to Buy for January 31st
- ADMA, EKSO and IKT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 31, 2024.
- 01/31/2024
|
New Strong Buy Stocks for January 31st
- ADMA, IKT, YPF, AVXL and EKSO have been added to the Zacks Rank #1 (Strong Buy) List on January 31, 2024.
- 01/31/2024
|
Why Is Ekso Bionics (EKSO) Stock Up 5% Today?
- Ekso Bionics (NASDAQ: EKSO ) stock is on the rise Friday without any clear news from the exoskeleton company this morning. There are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why the stock is up today.
- 01/26/2024
|
Ekso Bionics Launches GaitCoach Software for EksoNR
- SAN RAFAEL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the launch of GaitCoach™, its next generation gait therapy software for EksoNR.
- 01/08/2024
|
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results
- SAN RAFAEL, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced preliminary top line financial results for the fourth quarter and fiscal year ended December 31, 2023.
- 01/04/2024
|
Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29
- SAN RAFAEL, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Company will participate at the Centers for Medicare & Medicaid Services' (“CMS”) Healthcare Common Procedure Coding System (“HCPCS”) public meeting on November 29, 2023, to discuss appropriate Medicare payment for the Ekso Indego Personal.
- 11/16/2023
|
Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal
- Ruling Could Significantly Expand Use of Ekso Indego Personal in Home and Community Markets SAN RAFAEL, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, announces that the Centers for Medicare & Medicaid Services (“CMS”) finalized its Calendar Year 2024 Home Health Prospective Payment System Rule CMS-1780 (“2024 Home Health Rule”), which includes exoskeletons in the Medicare brace benefit category.
- 11/02/2023
|
Ekso Bionics (EKSO) Reports Q3 Loss, Tops Revenue Estimates
- Ekso Bionics (EKSO) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.33 per share a year ago.
- 10/26/2023
|
Ekso Bionics Holdings, Inc. (EKSO) Q3 2023 Earnings Call Transcript
- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q3 2023 Earnings Call October 26, 2023 4:30 PM ET Company Participants Matt Steinberg - Investor Relations Scott Davis - Chief Executive Officer Jason Jones - Chief Operating Officer Jerome Wong - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Greetings, and welcome to the Ekso Bionics Quarter Three 2023 Financial Results Call.
- 10/26/2023
|
Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%
- SAN RAFAEL, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and nine months ended September 30, 2023.
- 10/26/2023
|
Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023
- SAN RAFAEL, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2023 after the close of trading on Thursday, October 26, 2023. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
- 10/19/2023
|
Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
- SAN RAFAEL, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that Scott Davis, Chief Executive Officer, and Jerome Wong, Chief Financial Officer, will be participating in a fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference taking place in New York on September 11-13, 2023.
- 09/11/2023
|
Ekso Bionics (EKSO) Reports Q2 Loss, Tops Revenue Estimates
- Ekso Bionics (EKSO) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.23 per share a year ago.
- 07/27/2023
|
Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023
- SAN RAFAEL, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2023 after the close of trading on Thursday, July 27, 2023. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
- 07/20/2023
|
Ekso Bionics Holdings, Inc. (EKSO) Q1 2023 Earnings Call Transcript
- Ekso Bionics Holdings, Inc. (EKSO) Q1 2023 Earnings Call Transcript.
- 04/27/2023
|
Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023
- SAN RAFAEL, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2023 after the close of trading on Thursday, April 27, 2023. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
- 04/20/2023
|
Ekso Bionics Holdings, Inc. (EKSO) Q4 2022 Earnings Call Transcript
- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q4 2022 Earnings Conference Call March 28, 2023 4:30 PM ET Company Participants Matt Steinberg - Investor Relations, FINN Partners Scott Davis - Chief Executive Officer Jason Jones - Chief Operating Officer Jerome Wong - Chief Financial Officer Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Operator Greetings, and welcome to the Ekso Bionics Fourth Quarter 2022 Financial Results Conference Call.
- 03/28/2023
|
Ekso Bionics Holdings, Inc. (EKSO) Q3 2022 Earnings Call Transcript
- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Matt Steinberg - Investor Relations Steven Sherman - Chairman and Chief Executive Officer Scott Davis - President and Chief Operating Officer Jerome Wong - Chief Financial Officer Operator Greetings and welcome to Ekso Bionics Third Quarter 2022 Financial Results Call. [Operator Instructions] As a reminder, this conference is being recorded.
- 11/06/2022
|
Ekso Bionics (EKSO) Reports Q3 Loss, Lags Revenue Estimates
- Ekso Bionics (EKSO) delivered earnings and revenue surprises of -37.50% and 7.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/03/2022
|
Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference
- SAN RAFAEL, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that Scott Davis, President and Chief Operating Officer, will be presenting virtually at the H.C. Wainwright 24th Annual Global Investment Conference taking place September 12-14, 2022.
- 09/06/2022
|
Ekso Bionics: Fragile Opportunity
- Ekso Bionics has added a new use case for the EksoNR exoskeleton, multiple sclerosis, opening some new avenues for marginal revenue growth. Pre-Covid, Ekso had started to see sharp improvements in operating margins, but that trend came to a clear stop over the last two years.
- 08/24/2022
|
Ekso Bionics Holdings, Inc. (EKSO) CEO Steven Sherman on Q2 2022 Results - Earnings Call Transcript
- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q2 2022 Results Conference Call July 28, 2022 4:30 PM ET Company Participants David Carey - Head, Investor Relations Steven Sherman - Chairman & CEO Scott Davis - President & Chief Operating Officer Jerome Wong - interim Chief Financial Officer Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Kyle Bauser - LakeStreet Capital Operator Hello, and welcome to the Ekso Bionics Q2 2022 Financial Results Conference Call.
- 07/28/2022
|
Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates
- Ekso Bionics (EKSO) delivered earnings and revenue surprises of 4.17% and 0.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 07/28/2022
|
Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28
- RICHMOND, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2022 after the close of trading on Thursday, July 28, 2022. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
- 07/21/2022
|
Ekso Bionics (EKSO) Reports Q1 Loss, Lags Revenue Estimates
- Ekso Bionics (EKSO) delivered earnings and revenue surprises of 12.20% and 19.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 04/28/2022
|
Ekso Bionics to Report First Quarter 2022 Financial Results on April 28
- RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2022 after the close of trading on Thursday, April 28, 2022. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
- 04/21/2022
|
Ekso Bionics Holdings, Inc. (EKSO) CEO Steven Sherman on Q4 2021 Results - Earnings Call Transcript
- Ekso Bionics Holdings, Inc. (EKSO) CEO Steven Sherman on Q4 2021 Results - Earnings Call Transcript
- 02/24/2022
|
Ekso Bionics to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
- RICHMOND, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2021 after the close of trading on Thursday, February 24, 2022. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
- 02/17/2022
|
Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q3 2021 Results - Earnings Call Transcript
- Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q3 2021 Results - Earnings Call Transcript
- 11/02/2021
|
Ekso Bionics (EKSO) Reports Q3 Loss, Tops Revenue Estimates
- Ekso Bionics (EKSO) delivered earnings and revenue surprises of 32.00% and 18.18%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/02/2021
|
Ekso Bionics to Report Third Quarter 2021 Financial Results on November 2, 2021
- RICHMOND, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2021 after the close of trading on Tuesday, November 2, 2021. Management will host a conference call beginning at 1:30 p.m. PT, 4:30 p.m. ET to discuss the financial results and recent business developments.
- 10/26/2021
|
Ekso Bionics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference
- RICHMOND, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that management will participate in a fireside chat at the H.C. Wainwright 23rd Annual Global Investor Conference held on September 13 - 15, 2021.
- 09/07/2021
|
Ekso Bionics (EKSO) Reports Q2 Loss, Tops Revenue Estimates
- Ekso Bionics (EKSO) delivered earnings and revenue surprises of -4.00% and 3.32%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 07/29/2021
|
Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q2 2021 Results - Earnings Call Transcript
- Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q2 2021 Results - Earnings Call Transcript
- 07/29/2021
|
Ekso Bionics Reports Second Quarter 2021 Results
- RICHMOND, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended June 30, 2021.
- 07/29/2021
|
Moving Average Crossover Alert: Ekso Bionics (EKSO)
- Ekso Bionics (EKSO) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
- 05/13/2021
|
New Strong Sell Stocks for May 5th
- BLKB, CTXS, EKSO, FHI, and GCI have been added to the Zacks Rank #5 (Strong Sell) List on May 5, 2021
- 05/05/2021
|
Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q1 2021 Results - Earnings Call Transcript
- Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q1 2021 Results - Earnings Call Transcript
- 04/29/2021
|
Ekso Bionics Holdings: Q1 Earnings Insights
- Shares of Ekso Bionics Holdings (NASDAQ:EKSO) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 22.73% year over year to ($0.34), which missed the estimate of ($0.24).
- 04/29/2021
|
Ekso Bionics Reports First Quarter 2021 Results
- RICHMOND, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2021.
- 04/29/2021
|
Will Ekso Bionics (EKSO) Report Negative Q1 Earnings? What You Should Know
- Ekso Bionics (EKSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/22/2021
|
Ekso Bionics (EKSO) Surges 9.4%: Is This an Indication of Further Gains?
- Ekso Bionics (EKSO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- 04/12/2021
|
Ekso Bionics Announces Partnership with U.S. Physiatry to Support Physician Education of EksoNR
- RICHMOND, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced a partnership with U.S. Physiatry (USP) to educate physicians on the clinical benefits of an EksoNR exoskeleton. USP is the largest inpatient physician practice in the U.S. focused exclusively on physical medicine and rehabilitation. The partnership will help expand awareness of Ekso Bionics' technology among physicians and other rehabilitation clinicians as well as educate on how to successfully implement robotics into a rehabilitation program.
- 03/09/2021
|
Ekso Bionics' (EKSO) CEO Jack Peurach on Q4 2020 Results - Earnings Call Transcript
- Ekso Bionics' (EKSO) CEO Jack Peurach on Q4 2020 Results - Earnings Call Transcript
- 02/25/2021
|
Recap: Ekso Bionics Holdings Q4 Earnings
- Shares of Ekso Bionics Holdings (NASDAQ:EKSO) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 1100.00% over the past year to ($0.48), which missed the estimate of ($0.30).
- 02/25/2021
|
Earnings Preview: Ekso Bionics Holdings
- On Thursday, February 25, Ekso Bionics Holdings (NASDAQ:EKSO) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.
- 02/24/2021
|
Ekso Bionics Announces Closing of $40 Million Bought Deal Offering
- RICHMOND, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced the closing of its previously announced underwritten public offering of 3,902,440 shares of common stock of Ekso Bionics, at a price to the public of $10.25 per share, less underwriting discounts and commissions. As previously announced, Ekso Bionics also has granted to the underwriter a 30-day option to purchase up to an additional 585,366 shares of common stock at the public offering price, less underwriting discounts and commissions.
- 02/11/2021
|
Ekso Bionics Increases Previously Announced Bought Deal Offering of Common Stock to $40 Million
- RICHMOND, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 3,902,440 shares of common stock of Ekso Bionics, at a price to the public of $10.25 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about February 11, 2021, subject to the satisfaction of customary closing conditions.
- 02/08/2021
|
Ekso Bionics Announces $10 Million Bought Deal Offering Of Common Stock
- RICHMOND, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 975,610 shares of common stock of Ekso Bionics, at a price to the public of $10.25 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about February 11, 2021, subject to the satisfaction of customary closing conditions.
- 02/08/2021
|
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2020 Financial Results
- RICHMOND, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced preliminary top line financial results for the fourth quarter and fiscal year ended December 31, 2020.
- 01/13/2021
|
Ekso Bionics' Stockholders Elect Mary Ann Cloyd and Rhonda A. Wallen to its Board of Directors
- RICHMOND, Calif., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the election of Mary Ann Cloyd and Rhonda A. Wallen to its Board of Directors by vote of stockholders at its 2020 Annual Meeting on December 29, 2020, effective immediately.
- 12/30/2020
|
Is Ekso Bionics Holdings, Inc. (EKSO) A Good Stock To Buy Now?
- In this article you are going to find out whether hedge funds think Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting for known risk attributes. It's not surprising given that hedge funds have access to better information and more resources to predict the winners in the stock market.
- 11/27/2020
|
Ekso Bionics Announces Continued Adoption of EVO™ with Flexible Subscription-Based Order from Cloverdale Foods Company
- RICHMOND, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the continued adoption of its latest industry exoskeleton innovation, EVO, with a subscription-based order by Cloverdale Foods Company, a fourth generation, family-owned meat company.
- 11/10/2020
|
Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q3 2020 Results - Earnings Call Transcript
- Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q3 2020 Results - Earnings Call Transcript
- 10/29/2020
|
Ekso Bionics Reports Third Quarter 2020 Results
- RICHMOND, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended September 30, 2020.
- 10/29/2020
|
Military Wearable Market Global Insights, Demand and Rising Trends 2020 to 2026
- Oct 03, 2020 (Market Insight Reports) --
Global Military Wearable Market research report published by market insight reports explores the current outlook in...
- 10/03/2020
|
Bionic Devices Market SWOT Study, Type, PESTEL Analysis and Future Strategies | ABIOMED Inc, Touch Bionics Inc, Baxter AG
- Sep 29, 2020 (WiredRelease via Comtex) --
MarketResearch.Biz has posted a newly modern statistical statistics, titled as Bionic Devices Market. It is a...
- 09/29/2020
|
Science foundation discusses funding giant Hawaii telescope
- The National Science Foundation has launched an informal outreach to Hawaii about possible funding efforts for the stalled Thirty Meter Telescope project
- 08/21/2020
|
Science foundation discusses funding giant Hawaii telescope
- The National Science Foundation has launched an informal outreach to Hawaii about possible funding efforts for the stalled Thirty Meter Telescope project
- 08/21/2020
|
Science foundation discusses funding giant Hawaii telescope
- HONOLULU (AP) - The National Science Foundation has launched an informal outreach to Hawaii about possible funding efforts for the stalled Thirty Meter Telescope project.
The effort by the nation's top funder of basic research could lead to a huge influx of cash for the astronomy project on Mauna Kea with an estimated cost of $2.4 billion, The Honolulu Star-Advertiser reported Thursday.
Funding efforts could also trigger a regulatory process adding two years or more to a construction timeline that is far behind schedule. The project recently announced the start of construction was delayed until spring.
The foundation said in a statement it plans to reach out to "stakeholders, including Native Hawaiians," to understand their viewpoints.
Protesters blocked the 6.27-mile (10-kilometer) access road to the summit of Mauna Kea, Hawaii's tallest mountain, in a demonstration against the project from July through December 2019. Telescope opponents said the project would desecrate land considered sacred by some Native Hawaiians.
The foundation said its outreach would serve as a precursor to a formal federal environmental review process.
The Thirty Meter Telescope project has teamed with the Giant Magellan Telescope planned in Chile and the U.S. National Optical-Infrared Astronomy Research Laboratory to propose the U.S. Extremely Large Telescope Program.
The partnership, which is partly an effort to obtain additional funding, proposes to offer U.S. astronomers complete viewing coverage of the skies in the Northern and Southern hemispheres.
Thirty Meter Telescope officials recently submitted a planning and design proposal to the science foundation aimed at obtaining major funding for $1 billion added to the project's cost due to construction delays, inflation and other...
- 08/21/2020
|
Summer jobs for young people are vanishing with the pandemic
- The iconic summer job for high school and college students has been on the wane for nearly 20 years
- 08/11/2020
|
Summer jobs for young people are vanishing with the pandemic
- The iconic summer job for high school and college students has been on the wane for nearly 20 years
- 08/11/2020
|
Relief Therapeutics Discovers A Promising COVID-19 Killer (OTCMKTS:RLFTF)
- Relief Therapeutics is in advanced clinical trials with their drug RLF-100 which aims to halt COVID-19 and reverse its devastating effects; Just-released Compassionate Use results showed stunning results: ventilator-dependent Covid-19 patients with deadly co-morbidities coming off the ventilator and returning home in only five days after treatment with RLF-100; Relief Therapeutic's RLF-100 is both easy to manufacture at scale and inexpensive, meaning that success in clinical trials could translate to rapid worldwide production and availability; If in-progress clinical trials reflect the Compassionate Use results, RLF-100 will likely garner immediate approval and shares could go much higher.
- 08/11/2020
|
General Automation Lab Technologies and CosmosID Launch Second Microbiome Challenge
- Winner will receive complimentary sample processing and analysis for high-throughput characterization of microbial communities.
- 08/11/2020
|
This Week in Washington IP: Injunctions for SEPs, How Innovation Flourishes in Freedom, and Reviewing SBIR/STTR at the National Science Foundation
- This week in Washington IP, both houses of Congress are quiet during August recess but patent and IP policy issues are front and center at the Hudson Institute, which is hosting events to explore how light regulatory frameworks can increase innovation and the importance of injunctions for SEP owners.
- 08/10/2020
|
CENIC Extends 400G Capabilities to Coastal Path Between Los Angeles and Sunnyvale
- CENIC is now able to provide high-capacity services, from 100G to 400G and beyond, on its coastal path between Los Angeles and Sunnyvale. The research
- 08/07/2020
|
White House unveils partnership to boost quantum science education
- White House unveils partnership to boost quantum science education
- 08/05/2020
|
Ekso Bionics (NASDAQ:EKSO) Receives “Buy” Rating from HC Wainwright
- HC Wainwright restated their buy rating on shares of Ekso Bionics (NASDAQ:EKSO) in a research report released on Friday, AnalystRatings.com reports. HC Wainwright currently has a $12.00 price target on the stock. Several other brokerages also recently weighed in on EKSO. Zacks Investment Research downgraded shares of Ekso Bionics from a buy rating to a […]
- 08/04/2020
|
IgGenix Completes $10 Million Series A Financing
- IgGenix, Inc, today announced it completed a $10 million Series A financing. The financing was led by Khosla Ventures with participation from Parker V
- 08/04/2020
|
Fluidigm COVID-19 Funding, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:FLDM)
- Fluidigm receives NIH funding for COVID-19 testing technology. Stereotaxis receives positive fillip from first integrated cardiac ablation procedure.
- 08/03/2020
|
AbCellera Provides COVID-19 Program Update with the Start of Phase 3 Clinical Trials and the Expansion of its COVID-19 Antibody Database
- AbCellera today announced that LY-CoV555, a potential treatment and prophylaxis for COVID-19, has progressed to Phase 3 clinical trials.
- 08/03/2020
|
US Covid testing has been a historic catastrophe. Is Trump’s testing tsar Brett Giroir to blame?
- Giroir’s qualifications have come under increasing scrutiny as the US death toll tops 150,000, and testing continues to lag
- 07/31/2020
|
Ekso Bionics (EKSO) Reports Q2 Loss, Tops Revenue Estimates
- Ekso Bionics (EKSO) delivered earnings and revenue surprises of 0.00% and 22.38%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 07/30/2020
|
Ekso Bionics Reports Second Quarter 2020 Results
- RICHMOND, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended June 30, 2020. Recent Highlights and Accomplishments * Reported revenue of $2.3 million in the second quarter of 2020 * Record quarterly gross margins of approximately 56% in the second quarter of 2020, compared to 48% in the same period of 2019 * Raised total gross proceeds of $11.1 million in the June financing and subsequent exercises of warrants * Received FDA clearance to market the Company’s EksoNR™ robotic exoskeleton for use with acquired brain injury patients, in addition to previously cleared spinal cord and stroke applications, expanding the number of patients that can use the device * Named “Best Healthcare Robotics Company” in 2020 MedTech Breakthrough Awards Program“We are pleased with our team’s strong execution in navigating through an extraordinarily difficult environment,” said Jack Peurach, President and Chief Executive Officer of Ekso Bionics. “Through our virtual selling approach, we maintained a strong order pipeline by staying connected with our customer rehabilitation centers and network operators in delivering online service support and training. Operationally, at the start of the COVID-19 pandemic we took immediate actions to adjust our cost structure, enabling us to adapt to the new environment under these challenging market conditions. While the pandemic may impact the near-term outlook for the customers that we serve, we remain flexible both strategically and operationally to create long-term value for patients, customers, and our shareholders.”Second Quarter 2020 Financial ResultsRevenue for the quarter ended June 30, 2020 was $2.3 million, compared to $1.5 million in the first quarter of 2020 and $3.3 million for the same period in 2019. Revenue in the second quarter of 2020 included approximately $2.1 million in EksoHealth revenue, compared to $2.8 million in the same period in 2019, and approximately $0.2 million in EksoWorks sales, compared to $0.4 million in the same period in 2019. The decline in revenue as compared to the same period in 2019 was due to a decrease in volume of medical device sales driven by the impact of COVID-19, as customers delayed orders to prepare for and manage their business during the pandemic.Gross profit for the quarter ended June 30, 2020 was $1.3 million, compared to $1.6 million in the same period in 2019, representing a gross margin of approximately 56% in the second quarter of 2020, compared to a gross margin for the same period in 2019 of 48%. The decrease in gross profit is primarily attributed to lower volume of medical device sales.Sales and marketing expenses for the quarter ended June 30, 2020 were $1.7 million, a decrease of $1.3 million, or approximately 44%, compared to the same period in 2019. The decrease was primarily due to lower employee expenses and lower general marketing and trade show expenses.Research and development expenses for the quarter ended June 30, 2020 were $0.5 million, compared to $1.5 million for the same period in 2019, a decrease of $1.0 million, or approximately 70%. The decrease was primarily due to lower employee expenses and lower patent and licensing costs.General and administrative expenses for the quarter ended June 30, 2020 were $1.9 million, compared to $2.1 million for the same period in 2019, a decrease of $0.2 million, or approximately 8%.Loss on warrant liabilities for the quarter ended June 30, 2020 was $8.6 million due to the revaluation of warrants issued in 2015, 2019 and 2020, compared to a $2.7 million gain associated with the revaluation of warrants issued in 2015 and May 2019 for the same period in 2019.Net loss applicable to common stockholders for the quarter ended June 30, 2020 was $11.8 million, or $1.88 per basic and diluted share, compared to net loss of $3.1 million, or $0.65 per basic and diluted share, for the same period in 2019.Six months ended June 30, 2020Revenue for the six months ended June 30, 2020 was $3.7 million, which includes approximately $3.3 million in EksoHealth revenue, and $0.4 million in EksoWorks sales, compared to $6.9 million for the same period in 2019. The decrease in revenue for the six-month 2020 period was primarily due to the same reasons for the second quarter of 2020.Gross profit for the six months ended June 30, 2020 was approximately $1.9 million, representing a gross margin of approximately 51%, compared to gross profit of $3.2 million for the same period in 2019, representing a gross margin of 46%. The increase in gross margins was primarily due to higher average selling prices and lower production costs of EksoNR devices.Sales and marketing expenses for the six months ended June 30, 2020 were $4.2 million, compared to $5.8 million for the same period in 2019, a decrease of $1.6 million. The decrease was primarily due to lower employee expenses, lower general marketing and trade show expenses and a decrease in clinical trial activities due the completion of the Company’s main clinical trial in the first quarter of 2019.Research and development expenses for the six months ended June 30, 2020 were $1.2 million, compared to $2.9 million in the same period in 2019, a decrease of $1.7 million. The decrease was primarily due to the same reasons for the second quarter of 2020.General and administrative expenses for the six months ended June 30, 2020 were $4.1 million, compared to $4.4 million in the same period in 2019, a decrease of $0.3 million. The decrease was primarily due to a decrease in consulting expense and employee expenses.Loss on warrant liabilities for the first six months ended June 30, 2020 was $6.1 million due to the revaluation of warrants issued in 2015, 2019 and 2020, compared to a $1.6 million gain associated with the revaluation of warrants issued in 2015 and May 2019 for the same period in 2019.Net loss applicable to common shareholders for the six months ended June 30, 2020 was $14.3 million, or $2.37 per basic and diluted share, compared to $9.6 million, or $2.12 per basic and diluted share, for the same period in 2019.Cash on hand at June 30, 2020 was $13.3 million, compared to $10.9 million at December 31, 2019. In June 2020, the Company raised gross proceeds of $7.89 million in a registered direct offering priced at-the-market under Nasdaq rules and $0.8 million from the exercise of the warrants that were issued in the Company’s May 2019 underwritten public offering. In July 2020, the Company raised additional gross proceeds of $2.4 million from the exercise of the warrants that were issued in the June 2020 registered direct offering.China Joint Venture UpdateOn July 13, 2020, Ekso and partners in its China joint venture entered into a National Security Agreement (“NSA”), which, among other things, requires the termination of the Company’s agreements and role with the joint venture. Ekso intends to work cooperatively with the joint venture partners and Committee on Foreign Investment in the United States to implement the terms of the NSA.Conference CallManagement will host a conference call today beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the Company’s financial results and recent business developments.Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 for international callers. A live webcast of the event will be available in the “Investors” section of the Company’s website at www.eksobionics.com, or by clicking here.A replay of the call will be available for two weeks by dialing 877-660-6853 for domestic callers or 201-612-7415 for international callers, using Conference ID: 13706452. The webcast will also be available on the Company’s website for one month following the completion of the call.About Ekso Bionics®Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on Twitter.Forward-Looking StatementsAny statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the design, development and commercialization of human exoskeletons, plans or strategy relating to the marketing and adoption and acceptance of the Company’s products and potential for adoption of the Company’s products by the market, and plans or strategy related managing the impact of the COVID-19 epidemic, (ii) estimates or projection of financial results, financial condition, capital expenditures, capital structure or other financial items, (iii) the Company's future financial performance, (iv) estimates or projections of sales and prospective customers, and (v) the assumptions underlying or relating to any statement described in points (i) through (iv) above.
- 07/30/2020
|
Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q2 2020 Results - Earnings Call Transcript
- Start Time: 16:30 End Time: 17:00 Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q2 2020 Earnings Conference Call July 30, 2020, 16:30 PM ET Company Participants Jack Peurach - President and CEO Jack Glenn - CFO Bill Shaw - Chief Commercial Officer David Carey - IR, Lazar Partners Ltd.
- 07/30/2020
|
Will Delayed Orders Hurt Ekso Bionics (EKSO) Q2 Earnings?
- Ekso Bionics (EKSO) Q2 earnings are expected to have been boosted by its recent efforts to grow virtual connectivity with customers and to reduce costs.
- 07/27/2020
|
Even as Indy Goes Autonomous, the Race to True Self-Driving Has Been Long
- In 2021 university teams will compete in an autonomous-car race at Indianapolis Motor Speedway. It’s a reminder how difficult the technology behind autonomous driving is.
- 07/25/2020
|
Ekso Bionics® to Report Second Quarter 2020 Financial Results on July 30, 2020
- RICHMOND, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2020 after the close of trading on Thursday, July 30, 2020. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments. Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 for international callers. A live webcast of the event will be available in the “Investors” section of the company’s website at www.eksobionics.com, or by clicking here.A replay of the call will be available for two weeks by dialing 877-660-6853 for domestic callers or 201-612-7415 for international callers and using Conference ID: 13706452. The webcast will also be available on the company’s website for one month following the completion of the call.About Ekso Bionics®Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on Twitter.Investor Contact: David Carey 212-867-1768 investors@eksobionics.comMedia Contact: Carrie Yamond Mas 917-371-2320 cmas@eksobionics.com
- 07/23/2020
|
Tasso Secures $17 Million Series A Financing to Scale Production of At-Home Blood Collection Systems and Capitalize on Growing Demand for Remote Diagnostic Testing
- Tasso Inc. completes an oversubscribed $17 million Series A financing round.
- 07/22/2020
|
Poll: Pandemic hurting Americans' finances in disparate ways
- As the coronavirus pandemic drags on, a new poll from NORC at the University of Chicago finds it's having different effects on Americans’ economic well-being
- 07/21/2020
|
Poll: Pandemic hurting Americans' finances in disparate ways
- As the coronavirus pandemic drags on, a new poll from NORC at the University of Chicago finds it's having different effects on Americans’ economic well-being
- 07/21/2020
|
Self-Driving Cars Will Race in Indianapolis. Tesla Can’t Take Part.
- Universities will compete in the Indianapolis 50 in 2021. It’s a new event helping bring autonomous driving to the masses.
- 07/20/2020
|
NeuroRx en Relief Therapeutics kondigen besluit van Data Monitoring Committee aan om Fase 2/3-onderzoek naar RLF-100 voor kritisch zieke COVID-19 patiënten met longfalen voort te zetten
- NeuroRx, Inc. heeft vandaag in samenwerking met RELIEF THERAPEUTICS Holdings AG (OTC:RLFTF, SIX:RLF) aangekondigd dat het onafhankelijke Data Monitori
- 07/17/2020
|
NeuroRx and Relief Therapeutics Announce Data Monitoring Committee Determination to Continue Phase 2/3 Trial of RLF-100 for Critical COVID-19
- The Data Monitoring Committee gave a positive opinion to continue the study of RLF-100 in patients with critical COVID-19 with respiratory failure.
- 07/16/2020
|
Engineers create a wireless camera that can ride atop an insect and send images back to a smartphone
- Engineers from the University of Washington have created the first wireless camera small enough to ride aboard a live insect. It weighs about 250mg, or about one-tenth the weight of a playing card, and can record images for six hours.
- 07/15/2020
|
Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate
- Medicago begins Phase I clinical trials for its COVID-19 vaccine candidate
First doses administered to human volunteers
- 07/14/2020
|
Nascent Devices, Inc. To Pay $70,000 To Resolve Potential False Claims Liability
- Nascent Devices, Inc. To Pay $70,000 To Resolve Potential False Claims Liability | STL.News - Read this and more news at STL.NEWS
- 07/13/2020
|
White House names Kratsios as Pentagon acting tech chief
- White House names Kratsios as Pentagon acting tech chief
- 07/13/2020
|
AI + IoT = 1000X More Dense Networking Environments: How Intel, NSF Are Planning For Tomorrow
- Device densities could hit MILLIONS in the coverage area of a single cell site ...
- 07/11/2020
|
US bets on untested company to deliver COVID-19 vaccine
- When precious vats of COVID-19 vaccine are finally ready, the ability to jab the lifesaving solution into the arms of Americans will require hundreds of millions of injections
- 07/10/2020
|
Army Distaff Foundation-Knollwood is First Life Plan Community to Adopt Ekso Bionics’ Exoskeleton Device for Rehabilitation Following Successful Trial
- WASHINGTON and RICHMOND, Calif., July 09, 2020 -- The Army Distaff Foundation (ADF), a non-profit charity in Washington, D.C., which operates Knollwood Military Life Plan.
- 07/09/2020
|
Boris Johnson's 'new deal' is Roosevelt lite
- The PM’S building bonanza involves a sleight of hand while Dominic Cummings’s plan to ape the Americans’ advanced tech agency is flawed
- 07/04/2020
|
University Researchers Seek Ways to Recycle ‘Unrecyclable’ Polymers
- Case Western Reserve and the University of Wisconsin-Madison are advancing new solutions for difficult-to-recycle polymers.
- 07/02/2020
|
National Science Foundation Awards Grant to Rensselaer Polytechnic for Research into New Plastic
- The researchers will investigate polymers with the properties of polystyrene but that can be easily depolymerized and converted into raw materials for re-use.
- 07/02/2020
|
Elizabeth Tallett Joins Moderna's Board of Directors
|
Researchers tracking COVID-19 in wastewater to join forces on framework for translating data into a public health response
|
Moderna : Elizabeth Tallett Joins Moderna's Board of Directors | MarketScreener
|
Reven Announces the Appointment of Eminent Physician-Scientist Fatih M. Uckun, M.D., Ph.D., Internationally Recognized for His Seminal Contributions to Oncology, Immunology and Immunity, as Its Chief Medical Officer and Chief Scientific Officer
- Reven Announces the Appointment of Eminent Physician-Scientist Fatih M. Uckun, M.D., Ph.D.
- 07/01/2020
|
Boris Johnson pledges to bring 'top digital and tech talent' to UK
- In a clear signal of the drive to revolutionise Whitehall, these experts will be parachuted in to government departments to provide a different perspective on how the country should be run.
- 06/30/2020
|
Extremely Warped Spacetime: To Find Giant Black Holes, Start With Jupiter
- The revolution in our understanding of the night sky and our place in the universe began when we transitioned from using the naked eye to a telescope in 1609. Four centuries later, scientists are experiencing a similar transition in their knowledge of black holes by searching for gravitational waves
- 06/30/2020
|
Global warming over 150 years has upended six MILLENNIA of cooling
- The world's temperatures have reached levels that may not have been seen over the past 125,000 years, researchers said. At that time sea levels were 20 feet higher than they are today.
- 06/30/2020
|
Tropical and Temperate Reefs Affected Differently by Fishing Pressures
- In a study published recently in Ecology and Evolution, an international team of researchers focused on what can happen to ocean ecosystems when fishing pressure increases or decreases, and how this differs between tropical to temperate marine ecosystems. The team, led by Elizabeth Madin, researcher
- 06/30/2020
|
Scientists Have Been Able to Capture the Light Emitted When Two Black Holes Collide
- Scientists have revealed the image of the light produced on the collision of two black holes.
- 06/30/2020
|
SFI on the future of Irish research in a post-Covid-19 world
- SFI director general Prof Mark Ferguson says that how Irish research operates will fundamentally change as a result of Covid-19.
- 06/30/2020
|
Major New Paleoclimatology Study Shows Last 150 Years of Global Warming Has Undone 6,500 Years of Cooling
- Comprehensive compilation of pre-historic temperature records shows that global warming is reaching levels not seen for at least 6,000 years. Over the past 150 years, global warming has more than undone the global cooling that occurred over the past six millennia, according to a major study publi
- 06/30/2020
|
Opinion: Immigration restrictions will hurt scientific competitiveness
- Our xenophobia is interfering with our scientific progress and limiting our scientific competitiveness
- 06/30/2020
|
South pole warming three times faster than rest of the world, our research shows | Kyle Clem for the Conversation
- Dramatic change in Antarctica’s interior in past three decades a result of effects from tropical variability working together with increasing greenhouse gases
- 06/30/2020
|
Senators Introduce Bill to Boost US Production of Semiconductors Amid Beijing's Threats
- In a move to counter China’s tech ambitions, a bipartisan group of senators has introduced legislation aimed to ...
- 06/29/2020
|
Multifunctional Nanofiber Protects Against Explosions – For Soldiers, Firefighters, Astronauts and More
- Since World War I, the vast majority of American combat casualties has come not from gunshot wounds but from explosions. Today, most soldiers wear a heavy, bullet-proof vest to protect their torso but much of their body remains exposed to the indiscriminate aim of explosive fragments and shrapnel.
- 06/29/2020
|
10 Bonus Autonomous Driving News Stories
- Continuing our series of end-of-month news roundups for stories we couldn't dedicate full pieces to but still seemed noteworthy, here are 10 autonomous driving stories worth a gander.
- 06/29/2020
|
Surprising Findings Beneath the Surface of Our Galaxy’s Water Worlds
- A team of researchers simulated conditions on water-rich exoplanets in the laboratory and learned something surprising about their geological composition. Out beyond our solar system, visible only as the smallest dot in space with even the most powerful telescopes, other worlds exist. Many of the
- 06/29/2020
|
Understanding the agricultural perspective of hailstorms
- One certainty about High Plains summers is the occurrence of hailstorms, some of which can be destructive on crops and property. But what do farmers actually think about hailstorms and
- 06/28/2020
|
Cell Publication Elucidates How SARS-CoV-2 Dramatically Rewires Important Cell Programming; Identifies Existing Therapeutics That May Fight COVID-19
|
Cell Publication Elucidates How SARS-CoV-2 Dramatically Rewires Important Cell Programming; Identifies Existing Therapeutics That May Fight COVID-19
- For the First Time, Images Show Rapid Spread of Infection May be Explained by Extensive Filopodia, Stringy Protrusions in Virally Infected Cells ...
- 06/28/2020
|
Clouds the Likely Cause of Increased Global Warming in Latest Generation of Climate Models
- New representations of clouds are making models more sensitive to carbon dioxide. As scientists work to determine why some of the latest climate models suggest the future could be warmer than previously thought, a new study indicates the reason is likely related to challenges simulating the forma
- 06/27/2020
|
Why go 'horse and buggy' to Mars when we could go supersonic?
- With fusion propulsion, we could make Mars and the rest of the near solar system infinitely more accessible and promising.
- 06/27/2020
|
Coronavirus Or Flu? Scientists Are Developing A Sensor Which Tests For Both Simultaneously
- In anticipation of the upcoming challenges of the coronavirus pandemic in conjunction with flu season, researchers from the University of Texas at Austin are developing a sensor which can differentiate between Covid-19 and the flu by testing a person for both simultaneously.
- 06/27/2020
|
Why Ekso Bionics Stock Is Trading Higher Today
- Ekso Bionics Holdings (NASDAQ: EKSO) shares were trading higher Friday on continued strength after the company received FDA clearance to market its EksoNR robotic exoskeleton.Ekso Bionics Holdings designs, develops and sells exoskeleton technology used in health care and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks.All of the company's operations are in the United States.The EksoHealth segment, which generates the majority of revenue, designs, engineers, manufactures and sells exoskeletons for applications in the medical markets.Ekso Bionics shares were trading up 16.25% at $8.48 on Friday at the time of publication. The stock has a 52-week high of $20.10 and a 52-week low of $2.25.Courtesy photo. See more from Benzinga * Amazon Buys Autonomous Driving Startup Zoox For A Reported B * Germany's Wirecard Investigation Brings Economic, Regulatory Models Into Question * Nike Posts Big Q4 Earnings Miss, Says 90% Of Stores Have Reopened(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 06/26/2020
|
Mystery of Earth’s Vanishing Crust Solved by MagLab Geochemists – Prevailing Theories Contradicted
- Thank goodness for the Earth's crust: It is, after all, that solid, outermost layer of our planet that supports everything above it. But much of what happens below that layer remains a mystery, including the fate of sections of crust that vanish back into the Earth. Now, a team of geochemists bas
- 06/26/2020
|
Intel, NSF fund research into wireless-specific edge and machine learning
- Can artificial intelligence be trained to improve wireless network performance, classify emerging devices on a network, or conduct real-time machine learning at the network edge? Those are just a f…
- 06/26/2020
|
Retail sector faces transformative moment over Covid-19
- Long-term changes in customer behaviour and expectations await sector
- 06/26/2020
|
How to buy Moderna shares from Australia | 26 Jun price $61.515
- Ever wondered how to buy shares in Moderna in Australia? We explain how and compare the best share trading platforms.
- 06/26/2020
|
Carnegie Mellon Tool Automatically Turns Math Into Beautiful and Instructive Illustrations
- Some people look at an equation and see a bunch of numbers and symbols; others see beauty. Thanks to a new tool created at Carnegie Mellon University, anyone can now translate the abstractions of mathematics into beautiful and instructive illustrations. The tool enables users to create diagrams s
- 06/26/2020
|
Why Ekso Bionics Stock Is Trading Higher Today
- Ekso Bionics Holdings (NASDAQ: EKSO) shares were trading higher Friday on continued strength after the company received FDA clearance to market its EksoNR robotic...
- 06/26/2020
|
Prosecutors file more charges against Kansas professor
- BELLE PLAINE, Kan. (AP) - A Kansas researcher accused of concealing work he was doing for China while employed at the University of Kansas defrauded the U.S. government and the university, according to revised federal charges filed Thursday.
The new indictment charges Feng "Franklin" Tao of Lawrence, Kansas, with seven counts of wire fraud and three counts of making false statements. It also seeks, if convicted, the forfeiture of funds obtained from the offenses.
"Franklin Tao is not guilty of these charges, and looks forward to being fully vindicated so that he can move on with his life and his research," defense attorney Peter Zeidenbert said in an email.
Federal prosecutors allege that from May 2017 until August 2019, Tao schemed to obtain money and property from the university, the U.S. Department of Energy and the National Science Foundation.
The indictment alleges the purpose of the scheme was to benefit China by participating in its " talent plan," which prosecutors say is designed to encourage the transfer of original ideas and intellectual property from U.S. university to Chinese government institutions.
The indictment accuses Tao of not informing the University of Kansas that he was selected for the Changjiang Professorship or the salary for his appointment to Fuzhou University in Fuzhou, China.
Tao was first charged in November with one count of wire fraud and three counts of program fraud. A far more detailed indictment in January charged him with two counts of wire fraud and one count of program fraud. The latest indictment added more wire fraud counts along with the new counts of making false statements.
Tao, an associate professor of engineering at the University of Kansas, was born in China and moved to the United States in 2002. He has...
- 06/25/2020
|
Prosecutors file more charges against Kansas professor
- BELLE PLAINE, Kan. (AP) — A Kansas researcher accused of concealing work he was doing for China while employed at the University of Kansas defrauded the U.S. government and the university,...
- 06/25/2020
|
Smarter engineering could help recovery from major disasters
- While we must continue fighting the pandemic, we cannot neglect to prevent other natural disasters and environmental calamities from wreaking havoc on our communities. Smarter engineering can help.
- 06/25/2020
|
Thursday’s Stock Market Close: US Equities Rise In Volatile Session, Powered By Surging Bank Stocks
- U.S. stocks rose on Thursday although cases of covid-19 spiked in some states.
- 06/25/2020
|
Ekso Bionics News: Why EKSO Stock Is Skyrocketing 139% Today
- Ekso Bionics (EKSO) news for Thursday concerning approval from the FDA for one of its devices has EKSO stock soaring higher.
- 06/25/2020
|
‘Mystery object’ spotted by astronomers changes talk of black holes
- Astronomers have spotted a mystery object that they say could be a black hole or a neutron star. Both black holes and neutron stars are the remains of dead stars. “When the most massive stars die, …
- 06/25/2020
|
Ekso Bionics shares soar after company gets FDA clearance to use robotic exoskeleton in acquired brain injury
- Shares of Ekso Bionics Holdings Inc. undefined soared Thursday, after the company said it has received 501 clearance from the U.S. Food and Drug...
- 06/25/2020
|
Ekso Bionics shares soar after company gets FDA clearance to use robotic exoskeleton in acquired brain injury
- Shares of Ekso Bionics Holdings Inc. soared Thursday, after the company said it has received 501 clearance from the U.S. Food and Drug Administration to market its EksoNR robotic exoskeleton for use in patients with acquired brain injury, or ABI. The device is first to get FDA clearance for use with ABI, a category of brain injury that includes severe head injuries and concussions, as well as stroke, aneurysms, brain tumors, anoxia, degenerative and metabolic conditions, infections, and surgical injuries, among others, the company said in a statement. "Combined annual incidence of TBI and stroke alone represent an estimated patient population of 3.7 million in the U.S. and 84 million globally," said the statement. The FDA has already cleared the device for use in stroke and spinal cord injury. Ekso, based in Richmond, California, had a net loss of $2.5 million in its latest quarter, narrower than the loss of $6.6 million posted in the year-earlier period. Revenue came to $1.5 million, down from $3.6 million, as the pandemic led some customers to delay orders. Shares were last up 137%.
- 06/25/2020
|
Stocks Mixed as Bank Sector Surges - Schaeffer's Investment Research
- Stocks are flat midday thanks to rallying bank stocks, having pared steeper early morning losses brought on by economic data and COVID-19 concerns
- 06/25/2020
|
Flares of light likely created by colliding black holes seen for first time
- The research involved in international team of scientists.
- 06/25/2020
|
Intel : and National Science Foundation Invest in Wireless-Specific Machine Learning Edge Research | MarketScreener
|
Astronomers Find Evidence Black Hole Collision Exploded With Light
- Possible light flare observed from small black holes within the disk of a massive black hole. When two black holes spiral around each other and ultimately collide, they send out ripples in space and time called gravitational waves. Because black holes do not give off light, these events are not
- 06/25/2020
|
Ekso Bionics® Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Acquired Brain Injury Patients
- Ekso Bionics Holdings, Inc. (EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced it has received 501(k) clearance from the U.S. Food and Drug Administration (FDA) to market its EksoNRTM robotic exoskeleton for use with patients with acquired brain injury (ABI). EksoNR is the first exoskeleton device to receive FDA clearance for rehabilitation use with ABI, significantly expanding the device’s indication to a broader group of patients. EksoNR is the next generation device of the most clinically used robotic exoskeleton, and was previously cleared by the FDA for stroke and spinal cord injury rehabilitation in 2016.
- 06/25/2020
|
Neuer COVID-19-Prognose des IHME zufolge hat Großbritannien bis zum
1. Oktober fast 50.000 Todesfälle zu erwarten
- Auch in Italien und Frankreich ist mit einer hohen Zahl von Todesopfern zu rechnen; in der Türkei wird ein erneuter Ausbruch vorhergesagt
- 06/25/2020
|
Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine Candidate | | IT Business Net
- CAMBRIDGE, Mass. & SOMERSET, N.J.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new g
- 06/25/2020
|
Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine Candidate | | IT Business Net
- CAMBRIDGE, Mass. & SOMERSET, N.J.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new g
- 06/25/2020
|
Trump Shores Up Industrial Base for Hypersonic Missiles
- President Donald Trump is securing the supply of composite materials needed for hypersonic missiles, strategic missiles, and space launch systems.
- 06/25/2020
|
Dotmatics Buys BioBright | FinSMEs
- Dotmatics Ltd., a Herts, England-based scientific informatics software and services company, is to acquire BioBright LLC, a Boston, MA-based leader in automating the flow of data from laboratory instruments to a secure cloud
- 06/25/2020
|
Informatica teams up with Adapt Centre for AI collaboration
- Company working with SFI-backed centre to help automate data management offerings
- 06/25/2020
|
Dotmatics Acquires BioBright to Accelerate Laboratory Data Automation for the Lab of the Future | | IT Business Net
- Complementary expertise provides a single vendor solution to streamline data workflows from 'instrument to insight', boosting research efficiency End-to-end data automation will increase rep
- 06/25/2020
|
UC Berkeley: Rogue's Gallery Of Dusty Star Systems Reveals Exoplanet Nurseries
- Esposito is first author of a paper describing the results that appeared June 15 in The Astronomical Journal.
- 06/25/2020
|
Astronomers Find Mystery Object in Mass Gap – “We’ve Been Waiting Decades to Solve This Mystery!”
- When the most massive stars die, they collapse under their own gravity and leave behind black holes; when stars that are a bit less massive die, they explode in a supernova and leave behind dense, dead remnants of stars called neutron stars. For decades, astronomers have been puzzled by a gap that l
- 06/25/2020
|
Dotmatics Acquires BioBright to Accelerate Laboratory Data Automation for the Lab of the Future
- Dotmatics acquires BioBright to accelerate laboratory data automation for the Lab of the Future
- 06/25/2020
|
Exoplanet Nurseries Revealed in Rogue’s Gallery of Dusty Star Systems
- Systematic survey of 104 nearby stars turns up 25 dust disks with evidence of planets. Astronomers this month released the largest collection of sharp, detailed images of debris disks around young stars, showcasing the great variety of shapes and sizes of stellar systems during their prime planet
- 06/24/2020
|
Pace University Receives $175G from National Science Foundation
- One of your neighbors posted in Neighbor News. Click through to read what they have to say. (The views expressed in this post are the author’s own.)
- 06/24/2020
|
Mystery Object Observed by LIGO --"The Strangest Black Hole Ever Detected?" | The Daily Galaxy
- Stephen Hawking once wrote about black holes that there is a singularity in our past which constitutes, in some sense, a beginning to the universe. On August 14, 2019, scientists with LIGO (Laser Interferometer Gravitational-Wave Observatory) and the Virgo detector in Italy, discovered of a mystery object of 2.6 solar masses as it […]
- 06/24/2020
|
inContext.ai Awarded $225K by the National Science Foundation to Develop Artificial Intelligence Tools for Healthcare
- Press Release inContext.ai, a developer of healthcare-centric information extraction software and AI-powered clinical applications, announced an award of $225K in National Science Foundation (NSF) funding. The inContext.ai platform improves physicians' interactions...
- 06/24/2020
|
“Enigmatic and Strange” – 300-Million-Year-Old Fish Resembles a Sturgeon, but With Key Differences
- Tanyrhinichthys mcallisteri recasts the notion of what it means to be a 'primitive' vertebrate, according to Penn paleontologists Lauren Sallan and Jack Stack. Sturgeon, a long-lived, bottom-dwelling fish, are often described as "living fossils," owing to the fact that their form has remained rel
- 06/24/2020
|
Indian-American scientist heads America’s top science funding body
- Unanimously confirmed by the Senate last week, Panchanathan, 58, from the Arizona State University, replaced White House Office of Science and Technology Policy (OSTP) Director Dr Kelvin Droegemeier who served as Acting Director of the National Science Foundation (NSF).
- 06/24/2020
|
MIT Engineers Develop Super-Strong Surgical Tape That Painlessly Detaches on Demand
- Removable adhesive could make it easier for surgeons to close up internal wounds. Last year, MIT engineers developed a double-sided adhesive that could quickly and firmly stick to wet surfaces such as biological tissues. They showed that the tape could be used to seal up rips and tears in lungs a
- 06/24/2020
|
Mysterious object 'swallowed' by black hole in major astronomical discovery
- Australian researchers are part of an international team investigating the space 'merger'.
- 06/24/2020
|
Indian-American scientist heads America's National Science Foundation
- The term of previous NSF Director France Cordova's term ended in March 2020.On Monday, President Donald Trump formally appointed Panchanathan as the 15th Director of the NSF
- 06/24/2020
|
Indian-American scientist heads America's top science funding body
- His current position, which he has held for the past nine years at Arizona State University, has allowed him to lead the Knowledge Enterprise, which has advanced research, innovation, strategic partnerships, entrepreneurship and global and economic development, the NSF said. "Right now, the world faces significant scientific challenges - most obviously a pandemic, but in addition to providing creative solutions to address current problems, our eyes are on the future, leveraging partnerships at every level and encouraging diversity that breeds new ideas for a robust pipeline of young scientists," said Panchanathan.
- 06/24/2020
|
Existence of Two Giant Newborn Planets in PDS 70 System Confirmed by Astronomers
- New Direct Images Captured with W. M. Keck Observatory’s Upgraded Adaptive Optics System Lead to First Independent Confirmation of PDS 70 Protoplanets New evidence shows the first-ever pictures capturing the birth of a pair of planets orbiting the star PDS 70 are in fact authentic. Using a new
- 06/24/2020
|
UC Davis: What Hellman Awards Mean To Recipients
- "The recognition of the Hellman Fellowship also helped me strengthen my qualifications for other fellowships and awards."
- 06/24/2020
|
inContext.ai Awarded $225K by the National Science Foundation to Develop Artificial Intelligence Tools for Healthcare
- inContext.ai, a developer of healthcare-centric information extraction software and AI-powered clinical applications, announced an award of $225K in N
- 06/24/2020
|
Pentagon chief technology officer, deputy to resign on July 10
- The Pentagon’s chief technology officer Mike Griffin, an outspoken advocate for space-based missile defense systems, and his deputy will resign effective July 10 to set up their own company, the director of the Missile Defense Agency said.
- 06/23/2020
|
Gravitational waves reveal merger between black hole and mystery 'mass gap' object
- A mysterious astronomical object merged with a black hole 780 million light-years away and created gravitational waves that could be detected on Earth. The object exists inside what scientists call the "mass gap," a range between the heaviest known neutron star and the lightest known black hole. And it could change how astronomers understand black holes.
- 06/23/2020
|
Solid-State Laser Refrigeration of Nanoscale Sensors Achieved – Could Revolutionize Bio-Imaging and Quantum Communication
- To the general public, lasers heat objects. And generally, that would be correct. But lasers also show promise to do quite the opposite — to cool materials. Lasers that can cool materials could revolutionize fields ranging from bio-imaging to quantum communication. In 2015, University of Washi
- 06/23/2020
|
Indian-American Scientist Elected As Chief Of National Science Foundation
- Indian-American scientist Dr Sethuraman Panchanathan today officially took charge as Director of National Science Foundation (NSF), a day after US President Donald Trump appointed him as head of the top American body supporting fundamental research in non-medical fields of science and engineering.
- 06/23/2020
|
Appointed by Trump, Indian-American Scientist Heads America's National Science Foundation
- President Trump formally appointed Dr Sethuraman Panchanathan as the 15th Director of the NSF, the top American science funding body with an annual budget of $7.4 billion, the White House said, adding that it is a six-year term.
- 06/23/2020
|
Indian-American scientist heads America's top science funding body
- His current position, which he has held for the past nine years at Arizona State University, has allowed him to lead the Knowledge Enterprise, which has advanced research, innovation, strategic partnerships, entrepreneurship and global and economic development, the NSF said. "Right now, the world faces significant scientific challenges - most obviously a pandemic, but in addition to providing creative solutions to address current problems, our eyes are on the future, leveraging partnerships at every level and encouraging diversity that breeds new ideas for a robust pipeline of young scientists," said Panchanathan.
- 06/23/2020
|
Maps reveal lost underwater continent that connected Australia and New Zealand
- The new maps show where dinosaurs once roamed on the same landmass between the two countries and Antarctica. This is how you can see it for yourself.
- 06/23/2020
|
Keep GPS Working Coalition Launched Following FCC’s Controversial Ligado Order
- Five organizations representing thousands of companies and millions of Americans have launched a new coalition to protect end users of GPS following t
- 06/23/2020
|
Hear from US DoD and Milrem Robotics at Social Media in the Defence and Military Sector
- SMI reports: US DoD and Milrem Robotics join the speaker line-up for Social Media in the Defence and Military Sector conference
- 06/22/2020
|
Do we need a 'Quantum Generation'?
- From security to computing, quantum tech requires a new way of thinking.
- 06/21/2020
|
Black hole bombshell: Scientists stunned by monster black holes in dwarf galaxies
- ASTRONOMERS have made a startling discovery about black holes after finding gigantic versions of the mysterious entities in some of the smallest galaxies.
- 06/21/2020
|
Student fellowship to focus on rare White Mountain plants
- PLYMOUTH, N.H. (AP) - A Plymouth State University student has been awarded a National Science Foundation graduate research fellowship for her study of two rare alpine plants in the White Mountains.
Hannah Vollmer, of Thornton, is focusing on the dwarf mountain cinquefoil, or Robbins' cinquefoil, which exists nowhere else in the world but above the tree line in the White Mountains, and sibbaldia, which is typically found in Arctic regions.
Alpine plants in the White Mountains are remnants of glaciers that receded more than 13,000 years ago. Vollmer's research on the dwarf mountain cinquefoil seeks to provide evidence of the plant cloning itself by producing seeds without fertilization, or of genetic diversity and its evolution. Her research will also determine if the sibbaldia that grow in the White Mountains are genetically related to the sibbaldia plant found in Arctic climates, including Norway, Siberia and Alaska.
Vollmer is the first Plymouth State University student to earn the fellowship. She's also one of two grant recipients from the New England Botanical Club this year. She also received a grant from the American Society of Plant Taxonomists for this research.
- 06/21/2020
|
Student fellowship to focus on rare White Mountain plants
- PLYMOUTH, N.H. (AP) — A Plymouth State University student has been awarded a National Science Foundation graduate research fellowship for her study of two rare alpine plants in the White...
- 06/21/2020
|
US Senate confirms Indian-American scientist as head of America's top science funding body
- Dr Sethuraman Panchanathan, 58, from the Arizona State University, would head the NSF, the top American science funding body that has an annual budget of USD 7.4 billion.
- 06/20/2020
|
US Senate confirms Indian-American scientist as head of America’s top science funding body
- Panchanathan's years of experience in research and academia have prepared him for this role, said House Science, Space and Technology Committee Ranking Member Frank Lucas.
- 06/20/2020
|
US Senate confirms Indian-American scientist as head of America's top science funding body
- The US Senate has confirmed eminent Indian-American scientist Dr Sethuraman Panchanathan as the Director of the National Science Foundation, a top American body supporting fundamental research in non-medical fields of science and engineering.
- 06/20/2020
|
US Senate Confirms Indian-American Scientist as Head of America's Top Science Funding Body
- Dr Sethuraman Panchanathan, 58, from the Arizona State University, would head the NSF, the top American science funding body that has an annual budget of USD 7.4 billion.
- 06/20/2020
|
Senate confirms Indian-American scientist as head of America’s top science funding body
- Chairwoman Eddie Bernice Johnson of the House Science, Space and Technology Committee said that at this important moment in the Foundation’s history, “we pause” to celebrate the past 70 years of transformative discoveries while keeping eyes on the challenges ahead. “I have great confidence that Dr Panchanathan’s proven leadership and vision for disrupting the status quo will help usher in a bright future of scientific breakthroughs for the benefit of the American people.
- 06/20/2020
|
Engineers Put Tens of Thousands of Artificial Brain Synapses on a Single Chip for Portable AI Devices
- MIT engineers have designed a “brain-on-a-chip,” smaller than a piece of confetti, that is made from tens of thousands of artificial brain synapses known as memristors — silicon-based components that mimic the information-transmitting synapses in the human brain. The researchers borrowed from pri
- 06/19/2020
|
Chicago's Linda Liang: Tips to Keep Control in a Changing World
- One of your neighbors posted in Business. Click through to read what they have to say. (The views expressed in this post are the author’s own.)
- 06/19/2020
|
The Wild West Crypto Show Cheers as Fiat Money Gets Smart - NetworkNewsWire
- On episode 113 of the Wild West Crypto Show, titled “Bitcoin Inching Towards 10k,” hosts Drew Taylor and Brent Bates continued their straight shooting. The show, broadcast from their headquarters — some say hideout — in Kerrville, Texas, is meant to entertain, educate and keep the crypto community on top of the latest trends and … Continue reading "The Wild West Crypto Show Cheers as Fiat Money Gets Smart"
- 06/19/2020
|
How Martian meteorites helped scientists decode the red planet's geology
- Despite the pandemic, NASA is on track to launch its Mars rover, Perseverance, this July from Cape Canaveral, Florida. Its central mission will be to search for evidence of previous life on Mars. An exciting component of the rover will be a specialized drill that will collect rock and soil samples to be cached on …
- 06/19/2020
|
New Quantum Communication Technique Sends Information Using “Spooky Action at a Distance”
- Quantum communication—where information is sent through particles, typically entangled photons—has the potential to become the ultimate secure communication channel. Not only is it nearly impossible to eavesdrop on quantum communication, those who try will also leave evidence of their indiscretions.
- 06/19/2020
|
Assessment of COVID-19's Effect on Medical Exoskeleton Market 2020-2024 | Focus on Development of 3D-Printed Medical Exoskeletons to Augment Growth | Technavio
- The Global Medical Exoskeleton Market will grow by USD 351.68 mn during 2020-2024
- 06/19/2020
|
New Understanding of Ceramic Materials May Reveal Ways to Improve Solar Panels, Superconductors, and Biomedical Implants
- When most people think of ceramics, they might envision their favorite mug or a flowerpot. But modern technology is full of advanced ceramics, from silicon solar panels to ceramic superconductors and biomedical implants. Many of those advanced polycrystalline ceramics are combinations of crystall
- 06/18/2020
|
Dr. Linda Liang: Tips for Navigating Illinois Reopening and More
- One of your neighbors posted in Health & Fitness. Click through to read what they have to say. (The views expressed in this post are the author’s own.)
- 06/18/2020
|
Yale Scientists Solve a Thorny Problem: Where Do Thorns Come From?
- "Why do plants have thorns?" is an easy question: The thorns help protect against hungry animals that like to munch on the plants. "Where do thorns come from?" is a more complicated question — but Yale scientists have found an answer. Their insight, reported today in the June 18 issue of Current
- 06/18/2020
|
Commissioners Urge Hiring Changes to Fill Government Jobs in Cyber, AI
- Streamlining security clearance and subsidizing college costs might help land candidates as the private sector beckons.
- 06/18/2020
|
UC Davis: Noninvasive Fetal Oxygen Monitor Could Make For Safer Deliveries
- "We wondered if we could build a device to measure fetal blood oxygen saturation directly," said Soheil Ghiasi
- 06/18/2020
|
A leap forward in sustainability: EcoEnclose & Living Ink announce strategic partnership
- EcoEnclose and Living Ink officially partner to offer the world's most sustainable black ink to any company looking to print with black ink on paper packaging.
- 06/17/2020
|
Order From Disorder: Harnessing Turbulence in Light to Create a High-Precision Laser
- Using Turbulence to Generate Frequency Combs From Small Ring Lasers We’ve all experienced turbulent air and water, but did you know light can be turbulent too? An international team of researchers, led by Federico Capasso, the Robert L. Wallace Professor of Applied Physics and Vinton Hayes Seni
- 06/17/2020
|
Deeper Look at Dynamic Geological Processes Below Earth’s Surface With 3D Images
- Geoscientists at The University of Texas at Dallas recently used massive amounts of earthquake data and supercomputers to generate high-resolution, 3D images of the dynamic geological processes taking place far below the Earth’s surface. In a study published April 29, 2020, in Nature Communicatio
- 06/17/2020
|
Poll: Americans are the unhappiest they’ve been in 50 years
- Just 14% of American adults say they're very happy, down from 31% who said the same in 2018.
- 06/17/2020
|
Computing for a Cause: CPUcoin and BOINC to Power COVID-19 Research through IBM World Community Grid and Rosetta@home
- Incentivizing social responsibility, BOINC and CPUcoin let you earn cryptocurrency while supporting COVID-19 research
- 06/17/2020
|
Stevens' Plastic Waste Act Would Ramp Up Recycling
- The United States only recycles about 9% of its plastic waste.
- 06/17/2020
|
Air Force: SIMBA Chain $1.5M Blockchain Contract | PYMNTS.com
- The US Air Force looks into blockchain-based records for supply chain. A leader of Centra Tech pleads guilty. In Kazakhstan, leaders prepare for more crypto.
- 06/17/2020
|
CalTech Physicists Propose Innovative New Experiment for Detecting Dark Matter
- Thinking Small: New Ideas in the Search for Dark Matter Since the 1980s, researchers have been running experiments in search of particles that make up dark matter, an invisible substance that permeates our galaxy and universe. Coined dark matter because it gives off no light, this substance, which
- 06/17/2020
|
Battelle Wins NSF Funding to Track Viruses in Wastewater
- A Battelle team of researchers will test wastewater in Toledo for the presence of the virus that causes COVID-19 as well as other viral pathogens that
- 06/17/2020
|
Poll: Americans are the unhappiest they’ve been in 50 years
- The survey of 2,279 adults was conducted May 21-29 with funding from the National Science Foundation. It uses a sample drawn from NORC's probability-based AmeriSpeak Panel, which is designed to be representative of the U.S. population. The margin of sampling error for all respondents is plus or minus 2.9 percentage points.
- 06/16/2020
|
Americans are the unhappiest they've been in 50 years, poll says
- The survey finds that just 14% of American adults say they’re very happy, down from 31% who said the same in 2018. The survey draws on nearly a half-century of research from the General Social Survey, which has collected data on American attitudes and behaviors at least every other year since 1972.
- 06/16/2020
|
Americans are the unhappiest they've been in 50 years, survey suggests
- Americans are more unhappy today than they've been in nearly 50 years, a new poll suggests.
- 06/16/2020
|
Poll: Americans are the unhappiest they've been in 50 years
- ST. PETERSBURG, Fla. (AP) — It's been a rough year for the American psyche. Folks in the U.S. are more unhappy today than they've been in nearly 50 years. This bold — yet unsurprising — conclusion comes from the COVID Response Tracking Study, conducted by NORC at the University of Chicago. It finds that just 14% of American adults say they're very happy, down from 31% who said the same in 2018. That year, 23% said they'd often or sometimes felt isolated in recent weeks. Now, 50% say that. The survey, conducted in late May, draws on nearly a half-century of research from the General Social Survey, which has collected data on American attitudes and behaviors at least every other year since 1972. No less than 29% of Americans have ever called themselves very happy in that survey. Most of the new survey’s interviews were completed before the death of George Floyd touched off nationwide protests and a global conversation about race and police brutality, adding to the feelings of stress and loneliness Americans were already facing from the coronavirus outbreak — especially for black Americans. Lexi Walker, a 47-year-old professional fiduciary who lives near Greenville, South Carolina, has felt anxious and depressed for long stretches of this year. She moved back to South Carolina late in 2019, then her cat died. Her father passed away in February. Just when she thought she’d get out and socialize in an attempt to heal from her grief, the pandemic hit. “It’s been one thing after another,” Walker said. “This is very hard. The worst thing about this for me, after so much, I don’t know what’s going to happen.” Among other finding from the new poll about life in the pandemic: — The public is less optimistic today about the standard of living...
- 06/16/2020
|
How Happy Are Americans? Thanks To Coronavirus, Not Very
- The new COVID Response Tracking Study found that just 14 percent of American adults say they're very happy.
- 06/16/2020
|
Poll: Americans are the unhappiest they've been in 50 years
- ST. PETERSBURG, Fla. (AP) - Spoiler alert: 2020 has been rough on the American psyche. Folks in the U.S. are more unhappy today than they've been in nearly 50 years.
This bold - yet unsurprising - conclusion comes from the COVID Response Tracking Study, conducted by NORC at the University of Chicago. It finds that just 14% of American adults say they're very happy, down from 31% who said the same in 2018. That year, 23% said they'd often or sometimes felt isolated in recent weeks. Now, 50% say that.
The survey, conducted in late May, draws on nearly a half-century of research from the General Social Survey, which has collected data on American attitudes and behaviors at least every other year since 1972. No less than 29% of Americans have ever called themselves very happy in that survey.
Most of the new survey's interviews were completed before the death of George Floyd touched off nationwide protests and a global conversation about race and police brutality, adding to the feelings of stress and loneliness Americans were already facing from the coronavirus outbreak - especially for black Americans.
Lexi Walker, a 47-year-old professional fiduciary who lives near Greenville, South Carolina, has felt anxious and depressed for long stretches of this year. She moved back to South Carolina late in 2019, then her cat died. Her father passed away in February. Just when she thought she'd get out and socialize in an attempt to heal from her grief, the pandemic hit.
"It's been one thing after another," Walker said. "This is very hard. The worst thing about this for me, after so much, I don't know what's going to happen."
Among other finding from the new poll about life in the pandemic:
- The public is less optimistic today about the standard of...
- 06/16/2020
|
